Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #26,101 to #26,150.
- Fluocinonide Topical (patient information) (1 revision)
- Fluocortin (1 revision)
- Fluorene (1 revision)
- Fluorescence (1 revision)
- Fluorescence anisotropy (1 revision)
- Fluorescence correlation spectroscopy (1 revision)
- Fluorescence resonance energy transfer (1 revision)
- Fluorescent tag (1 revision)
- Fluoride (patient information) (1 revision)
- Fluoride poisoning (1 revision)
- Fluoride therapy (1 revision)
- Fluorinated ethylene propylene (1 revision)
- Fluorodopa F 18 (1 revision)
- Fluoroestradiol f 18 (1 revision)
- Fluorogenic (1 revision)
- Fluoronium (1 revision)
- Fluorouracil (patient information) (1 revision)
- Fluorouracil Topical (patient information) (1 revision)
- Fluoxetine detailed information (1 revision)
- Fluoxetine overdose (1 revision)
- Fluphenazine (patient information) (1 revision)
- Flurandrenolide Topical (patient information) (1 revision)
- Flurazepam (patient information) (1 revision)
- Flushing (physiology) (1 revision)
- Flutazolam (1 revision)
- Flutelmium (1 revision)
- Fluticasone Nasal Spray (patient information) (1 revision)
- Fluticasone Oral Inhalation (patient information) (1 revision)
- Fluticasone Topical (patient information) (1 revision)
- Fluticasone and Salmeterol Oral Inhalation (patient information) (1 revision)
- Fluticasone overdose (1 revision)
- Flutoprazepam (1 revision)
- Flutter valve (1 revision)
- Fluvastatin (patient information) (1 revision)
- Flux (metallurgy) (1 revision)
- Flybase (1 revision)
- Foaming agent (1 revision)
- Focal adhesion (1 revision)
- Focal length (1 revision)
- Focal neurologic signs (1 revision)
- Focal segmental glomerulosclerosis case study one (1 revision)
- Focal segmental glomerulosclerosis cost-effectiveness of therapy (1 revision)
- Focal segmental glomerulosclerosis future or investigational therapies (1 revision)
- Focal segmental glomerulosclerosis secondary prevention (1 revision)
- Foggy brain (1 revision)
- Foix–Alajouanine syndrome (1 revision)
- Folate deficiency case study one (1 revision)
- Folate deficiency imaging findings (1 revision)
- Foliate papillae (1 revision)
- Folic Acid overdose (1 revision)